SAMSUNG PHARM. Co., LTD. (KRX:001360)

Market Cap	204.71B +48.2%
Revenue (ttm)	44.29B -1.9%
Net Income	12.71B +306.8%
EPS	n/a
Shares Out	94.12M
PE Ratio	16.10
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	7,542,552
Average Volume	2,007,439
Open	2,030.00
Previous Close	2,090.00
Day's Range	1,987.00 - 2,320.00
52-Week Range	1,338.00 - 2,320.00
Beta	1.01
RSI	68.44
Earnings Date	n/a

About SAMSUNG PHARM. Co., LTD.

SAMSUNG PHARM. Co., LTD. manufactures and sells pharmaceutical products in South Korea. It offers prescription medicines, such as anticancer immunotherapy, antipyretic analgestic and antiinflammatory, antiobesity, hypotensive, antiarteriosclerotic, digestive organs, antophlegms, enzymes, ostepoposis, and transfusion agents, as well as skeletal muscle relaxants, anti-spastic, enzyme, mixed vitamins, antibiotics, and others. The company also provides medicines for the digestive system, medicines for liver disorders, medicines for the circulation ...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1929
• Employees: 240
• Stock Exchange: Korea Stock Exchange
• Ticker Symbol: 001360

Financial Performance

In 2024, SAMSUNG PHARM. Co., LTD.'s revenue was 44.29 billion, a decrease of -14.75% compared to the previous year's 51.96 billion. Earnings were 12.71 billion, a decrease of -48.77%.